These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 6654527)

  • 21. A time factor in the success or failure of immune rejection of transplanted tumors.
    Vaage J
    Cancer Res; 1977 Apr; 37(4):1064-7. PubMed ID: 844038
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cancer chemotherapy: past is prologue.
    Martin DS
    Mt Sinai J Med; 1985 Jun; 52(6):426-34. PubMed ID: 3875021
    [No Abstract]   [Full Text] [Related]  

  • 23. [Inhibitory effect of UFT on postoperative lung metastasis of mammary adenocarcinoma in SHR rats].
    Komatsumoto M; Li S; Hamada J; Takeichi N; Hosokawa M; Okayasu T; Tanabe T; Kobayashi H
    Gan To Kagaku Ryoho; 1988 May; 15(5):1739-45. PubMed ID: 3130810
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The role of an immunologic mechanism in the occurrence of postoperative metastases in mice].
    Iunker VM; Taraskina NP
    Vopr Onkol; 1988; 34(12):1471-7. PubMed ID: 2975423
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antitumor activity of menogaril alone, and in combination against human mammary cancer models in mice and rats.
    Yoshida M; Fujioka A; Nakano K; Kobunai T; Saito H; Toko T; Takeda S; Unemi N
    Anticancer Res; 1996; 16(3A):1155-9. PubMed ID: 8702227
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Role of the cellular inoculation dose in the development of the inhibitory effect of transplantable tumors on metastasis].
    Arkhipov SA; Iunker VM; Gruntenko EV
    Vopr Onkol; 1985; 31(3):77-83. PubMed ID: 3992963
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Targeting the primary tumor to generate CTL for the effective eradication of spontaneous metastases.
    Yu P; Lee Y; Wang Y; Liu X; Auh S; Gajewski TF; Schreiber H; You Z; Kaynor C; Wang X; Fu YX
    J Immunol; 2007 Aug; 179(3):1960-8. PubMed ID: 17641063
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Stimulation or inhibition of immune resistance against metastatic or local growth of a C3H mammary carcinoma.
    Vaage J; Agarwal S
    Cancer Res; 1976 May; 36(5):1831-6. PubMed ID: 1268839
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Therapy of primary and metastatic mouse mammary carcinomas with doxorubicin encapsulated in long circulating liposomes.
    Vaage J; Mayhew E; Lasic D; Martin F
    Int J Cancer; 1992 Jul; 51(6):942-8. PubMed ID: 1639542
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influence of immunosuppression on the growth of transplants of spontaneous mammary tumours in mice.
    Gruntenko EV
    Folia Biol (Praha); 1973; 19(6):414-9. PubMed ID: 4778992
    [No Abstract]   [Full Text] [Related]  

  • 31. Mammary tumor virus oncogenesis and tumor immunogenicity in three sublines of the C3H mouse.
    Vaage J; Medina D
    Cancer Res; 1978 Aug; 38(8):2443-7. PubMed ID: 208767
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Ambiguous action of splenocytes from tumor-bearing mice on the formation of metastases in the lungs of mice in an adaptive transfer system].
    Iunker VM; Arkhipov SA; Gruntenko EV
    Biull Eksp Biol Med; 1984 Nov; 98(11):598-600. PubMed ID: 6509179
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Non small cell lung cancer and chemotherapy.
    Nardini S
    Monaldi Arch Chest Dis; 1994 Apr; 49(2):177-8. PubMed ID: 8049706
    [No Abstract]   [Full Text] [Related]  

  • 34. Breast cancer in mice: effect of murine MUC-1 immunization on tumor incidence in C3H/HeOuj mice.
    Xing PX; Poulos G; McKenzie IF
    J Immunother; 2001; 24(1):10-8. PubMed ID: 11211144
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Experimental chemotherapy of human breast carcinomas transplanted into nude mice].
    Koh J; Asanuma F; Kurihara H; Konno H; Kubouchi K; Ikeda T; Enomoto K; Ishibiki K; Abe O; Kubota T
    Nihon Gan Chiryo Gakkai Shi; 1984 Aug; 19(7):1488-95. PubMed ID: 6440935
    [No Abstract]   [Full Text] [Related]  

  • 36. Sequential methotrexate and 5-FU in CMFP (cyclophosphamide, methotrexate, 5-FU, and prednisone) therapy for breast cancer.
    Cadman EC; Glick JH; Cross J; Horton J; Taylor SG
    Cancer Treat Rep; 1984 Jun; 68(6):877-9. PubMed ID: 6547367
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetic interactions of cyclophosphamide and 5-fluorouracil with methotrexate in an animal model.
    de Bruijn EA; Driessen O; Leeflang P; van den Bosch N; van Strijen E; Slee PH; Hermans J
    Cancer Treat Rep; 1986 Oct; 70(10):1159-65. PubMed ID: 3756938
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acute in vivo resistance in high-dose therapy.
    Teicher BA; Ara G; Keyes SR; Herbst RS; Frei E
    Clin Cancer Res; 1998 Feb; 4(2):483-91. PubMed ID: 9516940
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synergism between host anti-tumor immunity and combined modality therapy against murine breast cancer.
    Stolfi RL; Fugmann RA; Stolfi LM; Martin DS
    Int J Cancer; 1974 Mar; 13(3):389-403. PubMed ID: 4822108
    [No Abstract]   [Full Text] [Related]  

  • 40. Immunotherapeutic studies in mice with the methanol-extraction residue (mer) fraction of BCG: solid tumors.
    Yron I; Weiss DW; Robinson E; Cohen D; Adelberg MG; Mekori T; Haber M
    Natl Cancer Inst Monogr; 1973 Dec; 39():33-55. PubMed ID: 4362523
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.